(Q36579119)

English

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

scientific article published on 28 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

11

object named as

Karen Dybkær

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

object named as

Jane N Winter

29

0 references

Santiago Montes-Moreno

object named as

Santiago Montes-Moreno

10

0 references

Roberto N. Miranda

object named as

Roberto N Miranda

4

0 references

Michael Boe Møller

object named as

Michael B Møller

33

0 references

object named as

Govind Bhagat

15

0 references

Miguel A. Piris

object named as

Miguel A Piris

32

0 references

30

object named as

Ronald S Go

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Han van Krieken

22

object named as

J Han van Krieken

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Zijun Y Xu-Monette

3

object named as

Zijun Y Xu-Monette

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

12

object named as

April Chiu

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

William W L Choi

20

object named as

William W L Choi

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Maurilio Ponzoni

26

object named as

Maurilio Ponzoni

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

36

object named as

Ken H Young

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

13

object named as

Attilio Orazi

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Alexander Tzankov

2

object named as

Alexander Tzankov

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

19

object named as

X Frank Zhao

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

28

object named as

Brad S Kahl

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Emanuele S G d'Amore

8

object named as

Emanuele S G d'Amore

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cherie H Dunphy

17

object named as

Cherie H Dunphy

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Andrés J M Ferreri

27

object named as

Andres J M Ferreri

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Carlo Visco

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Yu Chuan Tai

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Yan Li

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Wei-min Liu

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Yong Li

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Youli Zu

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Huan-You Wang

16

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Eric D His

18

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Xiaoying Zhao

21

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Qin Huang

23

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Weiyun Ai

24

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Stacey O'Neill

25

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Stephan Dirnhofer

31

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Lin Wu

34

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Jeffrey Medeiros

35

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

28 August 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

98

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

255-263

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Ral GTPases and cancer: linchpin support of the tumorigenic platform

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

The BCL11 gene family: involvement of BCL11A in lymphoid malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

9 September 2017

Index for rating diagnostic tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

30 September 2017

18q21 rearrangement in diffuse large cell lymphoma: incidence and clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

28 June 2018

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Prognostic significance of the Bcl-2 negative germinal centre in patients with diffuse large B cell lymphoma treated with R-CHOP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Revised response criteria for malignant lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561433

20 September 2018

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of the bcl-2 gene in human follicular lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse large B-cell lymphoma in Chinese patients: immunophenotypic and cytogenetic analyses of 124 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2012.066209

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36579119&oldid=1835166669"